Biophysical characterization of E. coli TolC interaction with the known blocker hexaamminecobalt

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 11, 2017, Pages 2702-2709

  Gilardi, A ^a,b   Bhamidimarri, S P ^b   Bronstrup M ^c   Bilitewski, U ^c   Marreddy, R K R ^d   Pos, K M ^d   Benier, L ^b   Gribbon, P ^a   Winterhalter, M ^b   Windshugel B ^a  

^a FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^b JACOBS UNIVERSITY BREMEN   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Electrophysiology; Hexaamminecobalt; Surface plasmon resonance; TolC

Indexed keywords

CATION; ERYTHROMYCIN; FUSIDIC ACID; HEXAAMMINECOBALT; TOLC PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; COBALT; ESCHERICHIA COLI PROTEIN; HEXAAMMINECOBALT(II); OUTER MEMBRANE PROTEIN; TOLC PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN TARGETING; SURFACE PLASMON RESONANCE; ANTAGONISTS AND INHIBITORS; BIOPHYSICS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MULTIDRUG RESISTANCE;

BACTERIAL OUTER MEMBRANE PROTEINS; BIOPHYSICAL PHENOMENA; COBALT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; SURFACE PLASMON RESONANCE;

EID: 85026390639     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2017.07.014     Document Type: Article

References (36)

1. Holmes, A.H., Moore, L.S.P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P.J., Piddock, L.J.V., Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387 (2016), 176–187, 10.1016/S0140-6736(15)00473-0.
2. WHO | Antibiotic Resistance, 2016, WHO.
3. Li, X.Z., Plésiat, P., Nikaido, H., The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28 (2015), 337–418, 10.1128/CMR.00117-14.
4. Sun, J., Deng, Z., Yan, A., Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem. Biophys. Res. Commun. 453 (2014), 254–267, 10.1016/j.bbrc.2014.05.090.
5. Hassan, K.A., Liu, Q., Henderson, P.J.F., Paulsen, I.T., Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems. MBio 6 (2015), e01982–14, 10.1128/mBio.01982-14.
6. Tseng, T.T., Gratwick, K.S., Kollman, J., Park, D., Nies, D.H., Goffeau, A., Saier, M.H., The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1 (1999), 107–125.
7. Vaccaro, L., Scott, K.A., Sansom, M.S.P., Gating at both ends and breathing in the middle: conformational dynamics of TolC. Biophys. J. 95 (2008), 5681–5691, 10.1529/biophysj.108.136028.
8. Muller, R.T., Pos, K.M., The assembly and disassembly of the AcrAB-TolC three-component multidrug efflux pump. Biol. Chem. 396 (2015), 1083–1089, 10.1515/hsz-2015-0150.
9. Du, D., Wang, Z., James, N.R., Voss, J.E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., Luisi, B.F., Structure of the AcrAB-TolC multidrug efflux pump. Nature 509 (2014), 512–515, 10.1038/nature13205.
10. Du, D., van Veen, H.W., Luisi, B.F., Assembly and operation of bacterial tripartite multidrug efflux pumps. Trends Microbiol., 2015, 1–9, 10.1016/j.tim.2015.01.010.
11. Ge, Q., Yamadah, Y., Zgurskaya, E., The C-terminal domain of AcrA is essential for the assembly and function of the multidrug efflux pump AcrAB-TolC. J. Bacteriol. 191 (2009), 4365–4371, 10.1128/JB.00204-09.
12. Sulavik, M.C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K.J., Miller, G.H., Hare, R., Shimer, G., Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45 (2001), 1126–1136, 10.1128/AAC.45.4.1126-1136.2001.
13. Morona, R., Manning, P.A., Reeves, P., Identification and characterization of the ToIC protein, an outer membrane protein from Escherichia coli. J. Bacteriol. 153 (1983), 693–699.
14. Paulsen, I.T., Park, J.H., Choi, P.S., Saier, M.H., A family of Gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from Gram-negative bacteria. FEMS Microbiol. Lett. 156 (2006), 1–8, 10.1111/j.1574-6968.1997.tb12697.x.
15. Koronakis, V., Li, J., Koronakis, E., Stauffer, K., Structure of TolC, the outer membrane component of the bacterial type I efflux system, derived from two-dimensional crystals. Mol. Microbiol. 23 (1997), 617–626, 10.1046/j.1365-2958.1997.d01-1880.x.
16. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., Hughes, C., Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405 (2000), 914–919.
17. Daury, L., Orange, F., Taveau, J.C., Verchère, A., Monlezun, L., Gounou, C., Marreddy, R.K.R., Picard, M., Broutin, I., Pos, K.M., Lambert, O., Tripartite assembly of RND multidrug efflux pumps. Nat. Commun., 7, 2016, 10731, 10.1038/ncomms10731.
18. Jeong, H., Kim, J.S., Song, S., Shigematsu, H., Yokoyama, T., Hyun, J., Ha, N.C., Pseudoatomic structure of the tripartite multidrug efflux pump AcrAB-TolC reveals the intermeshing cogwheel-like interaction between AcrA and TolC. Structure 24 (2016), 272–276, 10.1016/j.str.2015.12.007.
19. Wang, Z., Fan, G., Hryc, C.F., Blaza, J.N., Serysheva, I.I., Schmid, M.F., Chiu, W., Luisi, B.F., Du, D., Jeon, H., Lee, K., Ha, N., Chiu, W., Bai, F., Rosenthal, P., Rossmann, M., Schmid, M., Schröder, G., Steven, A., Stokes, D., Westbrook, J., Wriggers, W., Yang, H., Young, J., Berman, H., Chiu, W., Kleywegt, G., Lawson, C., An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump. elife 6 (2017), 759–796, 10.7554/eLife.24905.
20. Fitzpatrick, A.W.P., Llabrés, S., Neuberger, A., Blaza, J.N., Bai, X.-C., Okada, U., Murakami, S., van Veen, H.W., Zachariae, U., Scheres, S.H.W., Luisi, B.F., Du, D., Structure of the MacAB–TolC ABC-type tripartite multidrug efflux pump. Nat. Microbiol., 2, 2017, 17070, 10.1038/nmicrobiol.2017.70.
21. Andersen, C., Hughes, C., Koronakis, V., Electrophysiological behavior of the TolC channel-tunnel in planar lipid bilayers. J. Membr. Biol. 185 (2002), 83–92, 10.1007/s00232-001-0113-2.
22. Andersen, C., Koronakis, E., Hughes, C., Koronakis, V., An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol. Microbiol. 44 (2002), 1131–1139, 10.1046/j.1365-2958.2002.02898.x.
23. Andersen, C., Koronakis, E., Bokma, E., Eswaran, J., Humphreys, D., Hughes, C., Koronakis, V., Transition to the open state of the TolC periplasmic tunnel entrance. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 11103–11108, 10.1073/pnas.162039399.
24. Higgins, M.K., Eswaran, J., Edwards, P., Schertler, G.F.X., Hughes, C., Koronakis, V., Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. J. Mol. Biol. 342 (2004), 697–702, 10.1016/j.jmb.2004.07.088.
25. Pos, K.M., Diederichs, K., Purification, crystallization and preliminary diffraction studies of AcrB, an inner-membrane multi-drug efflux protein. Acta Crystallogr. Sect. D Biol. Crystallogr. 58 (2002), 1865–1867, 10.1107/S0907444902013963.
26. Mueller, P., Rudin, D.O., Ti Tien, H., Wescott, W.C., Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature 194 (1962), 979–980, 10.1038/194979a0.
27. Okazaki, M., Kurabayashi, K., Asanuma, M., Saito, Y., Dodo, K., Sodeoka, M., VDAC3 gating is activated by suppression of disulfide-bond formation between the N-terminal region and the bottom of the pore. Biochim. Biophys. Acta Biomembr. 1848 (2015), 3188–3196, 10.1016/j.bbamem.2015.09.017.
28. Schwarz, G., Danelon, C., Winterhalter, M., On translocation through a membrane channel via an internal binding site: kinetics and voltage dependence. Biophys. J. 84 (2003), 2990–2998, 10.1016/S0006-3495(03)70025-3.
29. Bhamidimarri, S.P., Prajapati, J.D., van den Berg, B., Winterhalter, M., Kleinekathöfer, U., Role of electroosmosis in the permeation of neutral molecules: CymA and cyclodextrin as an example. Biophys. J. 110 (2016), 600–611, 10.1016/j.bpj.2015.12.027.
30. Balouiri, M., Sadiki, M., Ibnsouda, S.K., Methods for in vitro evaluating antimicrobial activity: a review. J. Pharm. Anal. 6 (2015), 71–79, 10.1016/j.jpha.2015.11.005.
31. Levy, S.B., Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36 (1992), 695–703.
32. Tikhonova, E.B., Dastidar, V., Rybenkov, V.V., Zgurskaya, H.I., Kinetic control of TolC recruitment by multidrug efflux complexes. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 16416–16421, 10.1073/pnas.0906601106.
33. Koronakis, V., Eswaran, J., Hughes, C., Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73 (2004), 467–489, 10.1146/annurev.biochem.73.011303.074104.
34. Myszka, D.G., Jonsen, M.D., Graves, B.J., Equilibrium analysis of high affinity interactions using BIACORE. Anal. Biochem. 265 (1998), 326–330, 10.1006/abio.1998.2937.
35. Nikaido, H., Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178 (1996), 5853–5859.
36. Krishnamoorthy, G., Tikhonova, E.B., Dhamdhere, G., Zgurskaya, H.I., On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein. Mol. Microbiol. 87 (2013), 982–997, 10.1111/mmi.12143.